Noteworthy, also patients whose tumour expressed high levels of E-cadherin (score 3+) had an unfavourable outcome when compared with patients with E-cadherin 2+ (HR=4.22; CI=1.41–12.66). This evidence concerns the gene CDH1 and neoplasm.